Crown Bioscience to Present Latest Advancements in Preclinical and Translational Platforms at AACR Annual Meeting 2019
15 posters present data from novel models to evaluate new cancer therapeutics
SAN DIEGO, March 21, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the presentation of 15 scientific posters at the American Association for Cancer Research (AACR) Annual Meeting in Atlanta, GA from March 29 to April 3.
The scientific posters highlight the latest advancements in CrownBio’s integrated oncology and immuno-oncology platforms built on the world’s largest and unique experimental model libraries, including patient-derived xenografts (PDXs), innovative humanized mouse models, GEMM, syngeneic mouse tumor homografts, PDX derived organoids (PDXO), and uniquely developed analytic methods.
Featured posters will present data from novel models that enable detailed evaluation of new cancer therapeutics, including targeted cancer immunotherapies and combination therapies with immune modulators.
"Our cutting-edge, proprietary platforms can enable rapid translation of a lead compound into a successful clinical candidate," said CrownBio's CSO, Dr. Henry Li. “The data presented at the conference will further demonstrate the validation of these platforms in oncology, particularly immuno-oncology research, which can greatly benefit our global pharmaceutical partners to advance their cancer drug discovery programs.”
Featured posters include:
Abstract 1503: Effect of immune cell depletion on the responses to anti-PD-1 treatment in syngeneic models (Monday Apr 1, 2019 8:00 AM - 12:00 PM) Various immune cell subpopulations were depleted in syngeneic tumor models to evaluate their contribution in anti-PD-1 mediated response.
Abstract 2375: Developing double knock-in models of human immune checkpoint targets (dKI HuGEMM™) for efficacy assessment of combinatorial therapeutic antibodies (Monday Apr 1, 2019 1:00 PM - 5:00 PM) Scientists generated human PD-1/PD-L1 and PD-1/CTLA-4 double knock-in models using CRISPR-Cas9 for the evaluation of combination therapies with human-specific immune checkpoint inhibitors.
Abstract 4976: Ex vivo functional characterization and in vivo efficacy validation of human CD40 agonistic antibodies in the human CD40 knock-in model (CD40 HuGEMM™) (Wednesday Apr 3, 2019 8:00 AM - 12:00 PM) A human CD40 knock-in model enables the assessment of dual functions of CD40.
The 15 poster abstracts and poster locations can be reviewed at: https://www.crownbio.com/aacr19-posters. All will be available for download from the CrownBio website after the AACR meeting. In addition, CrownBio experts will be at booth #2609 to discuss the various scientific translational platforms as well as current and future studies.
About Crown Bioscience Inc.
Crown Bioscience is a global drug discovery and development service company providing translational platforms to advance oncology and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.
Crown Bioscience Inc.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Følg saker fra GlobeNewswire
Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra GlobeNewswire
Bombardier Provides Preliminary First Quarter 2019 Financial Results, Updates 2019 Guidance25.4.2019 12:00:00 CEST | Pressemelding
First Quarter 2019 Consolidated Performance(1) Revenues expected to be ~$3.5B; driven lower by timing of aircraft deliveries, slower project ramp up at Transportation, and unfavourable currency translation Adjusted EBITDA(2) and adjusted EBIT(2) expected to be ~$265M and ~$170M, respectively, due to lower revenues and revised cost estimates on Transportation projects Free cash flow usage(2) expected to be ~$1.0B, supporting working capital investments 2019 Guidance(3) Update Consolidated revenue guidance now expected to be ~$1.0B lower at ~$17.0B, representing ~10% growth year over year, excluding currency effects and divestitures Aerospace businesses on track; Consolidated revenue guidance changed mainly due to revised Transportation outlook Consolidated adjusted EBITDA expectations reduced from $1.65-1.80B to $1.50-1.65B, representing a ~20% increase year over year Consolidated adjusted EBIT expectations reduced from $1.15-1.25B to $1.0-1.15B Consolidated free cash flow guidance rema
First Quarter 2019 Results Conference Call24.4.2019 19:55:00 CEST | Pressemelding
AURORA, Ontario, April 24, 2019 (GLOBE NEWSWIRE) -- Magna International Inc. (TSX: MG ) (NYSE: MGA ) FIRST QUARTER 2019 RESULTS CONFERENCE CALL THURSDAY – MAY 9, 2019 8:30 AM ET DIAL IN NUMBERS North America: 1-800-954-0587 International: 1-312-281-2942 Webcast: www.magna.com Slide presentation will be available on our website prior to the call. REBROADCAST INFORMATION Replay available 2 hours after the call until May 16, 2019 North America: 1-800-558-5253 International: 1-416-626-4100 Reservation No.: 21922562 INVESTOR CONTACT Louis Tonelli, Vice-President, Investor Relations firstname.lastname@example.org 905-726-7035 TELECONFERENCE CONTACT Nancy Hansford, Executive Assistant, Investor Relations email@example.com 905-726-7108
Flashpoint Strengthens Intelligence Platform with New Dashboards and Analytics, Expanded Collections and Tailored Alerting by Industry24.4.2019 16:00:00 CEST | Pressemelding
Company Significantly Expands Use-Case Driven Business Risk Intelligence (BRI) Offerings NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Flashpoint, the global leader in Business Risk Intelligence (BRI), today announced new innovations and enhancements that help multiple teams bolster cybersecurity, confront fraud, detect insider threats, enhance corporate and physical security, and address third-party risk. The new innovations and enhancements strengthen Flashpoint Intelligence Platform, which grants access to the company’s archive of finished intelligence reports, data from illicit forums, marketplaces, chat services, paste sites, technical data, card and account shops, and vulnerabilities, in a finished intelligence experience. The platform scales Flashpoint’s internal team of specialized, multilingual intelligence analysts’ ability to quickly provide responses to customers. “As a long-time Flashpoint customer, I have seen many iterations of the company’s platform, technology, and coll
VSBLTY LAUNCHES NEW CORPORATE WEBSITE;SHOWCASES MARKETING & SECURITY TECHNOLOGY24.4.2019 14:05:00 CEST | Pressemelding
Philadelphia, PA, April 24, 2019 (GLOBE NEWSWIRE) -- VSBLTY Groupe Technologies Corp. (CSE: VSBY) (Frankfurt: 5VS) is pleased to announce the launch of its new, upgraded website (vsblty.net) that demonstrates “The Intersection of Marketing & Security.” VSBLTY is a leading software technology company that provides consumer audience measurement using the power of machine learning through computer vision. Its industry-leading VisionCaptor™ and DataCaptor™ combines motion graphics or interactive brand messaging on any digital display at point of customer contact with “first of its kind” FacialAnalytics. VSBLTY’s measurement technology records demographics such as age, gender, and sentiment as well as audience measurement including content touches, traffic counts, and dwell time. Jay Hutton, VSBLTY Co-Founder and CEO, said, “Our website shows how our digital display solutions are transforming public spaces and providing actionable marketing insights. In addition, VSBLTY Vector™, our disrupt
Fiverr Adds Depth to Management Team, Announces Hila Klein as Chief Operating Officer24.4.2019 14:00:00 CEST | Pressemelding
The veteran executive brings over 15 years of leadership experience to the company as it continues to build upon its mission of changing how the world works together NEW YORK, April 24, 2019 (GLOBE NEWSWIRE) -- Fiverr, a marketplace that connects businesses with freelancers offering digital services, is proud to announce the appointment of Hila Klein as Chief Operating Officer. Klein has a strong background as a product and technology executive, having most recently served as a Senior Vice President, Head of Product Technologies Division at 888 Holdings. She will report directly to Fiverr CEO, Micha Kaufman. “Over the past year, Fiverr has grown both as a business and as an organization. That means the stakes are higher and the challenges are bigger,” said Micha Kaufman, Fiverr CEO. “As such, it was necessary for us to bring in someone to help us oversee all internal processes and procedures. Hila has demonstrated the leadership capabilities that are necessary to help us improve our cr
Qtum Launches Enterprise Blockchain Solution — Unita24.4.2019 10:00:00 CEST | Pressemelding
SHANGHAI, China, April 24, 2019 (GLOBE NEWSWIRE) -- Qtum, the open-source public blockchain platform, launched Unita, a blockchain protocol designed for enterprises. Unita securely stores data, utilizes existing developer tools and automates information transfer processes for businesses at a groundbreaking speed of 10,000 transactions per second. Unita’s flexibility allows a wide population of developers to use common tools to solve the biggest problems businesses face when considering adopting blockchain technology, including consumer data regulations and verification. Unita takes advantage of an innovative, unique, and scalable consensus algorithm, SCAR, that allows parameter adjustments to take place on the blockchain. The dynamic nature of SCAR saves substantial amounts of disk space, bandwidth, and other network resources. Miguel Palencia, Chief Information Officer of the Qtum Foundation, said: “Speed and customization are two of the main barriers for enterprises looking to adopt